Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When oxcarbazepine patent expired?How does protein binding influence lipitor's removal via kidneys?Pramlintide approval date?How does insurance coverage impact nivolumab's duration?Children's ibuprofen price?
See the DrugPatentWatch profile for nivolumab
For adults, nivolumab is most commonly given at 3 mg per kg (every 2 weeks) or 2 mg per kg (every 3 weeks).
Clinicians typically choose between the two standard adult regimens based on treatment setting and logistics, since both are weight-based (mg/kg) and correspond to commonly used dosing schedules: 3 mg/kg q2w or 2 mg/kg q3w.
“Per kg” means the prescribed dose is calculated from the patient’s body weight in kilograms, using one of the above mg/kg regimens, then rounded according to the facility’s dosing/infusion policies.
The mg/kg values above are the standard adult dosing patterns, but exact regimens can vary by indication and whether nivolumab is being used alone or with other therapies. If you share the indication (e.g., melanoma, lung cancer, kidney cancer) and schedule (q2w vs q3w), I can help match the dose to that context.
Other Questions About Nivolumab :